Washington, United States,
08048034981
curosurf poractant alfa injection (80 mg / 1.5 ml)
Benefits :
1.Rescue Treatment for RDS: It is used to treat premature infants suffering from RDS, a condition often caused by insufficient surfactant in the lungs.
2.Prevention of RDS: It may be used to prevent RDS in high-risk premature babies.
3.Improved Respiratory Function: By acting as a surfactant, it reduces surface tension within the lungs, preventing alveolar collapse (atelectasis) and improving lung compliance.
4.Reduced Mortality: It helps lower the risk of death and the occurrence of pneumothoraces (collapsed lung) in babies with immature lungs.

Apr 9th, 2026 12:00 PM

Keywords